4.5 Article

An approach for differentiating echovirus 30 and Japanese encephalitis virus infections in acute meningitis/encephalitis: a retrospective study of 103 cases in Vietnam

期刊

VIROLOGY JOURNAL
卷 10, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1743-422X-10-280

关键词

Echovirus 30; Japanese encephalitis virus; Acute meningitis/encephalitis

类别

资金

  1. Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan
  2. Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through Japan Society for the Promotion of Science
  3. Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through Global COE Program
  4. Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through Japan Initiative for Global Network on Infectious Diseases (J-GRID)
  5. Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through Young Researcher Overseas Visits Program for Vitalizing Brain Circulation
  6. Ministry of Health, Labour, and Welfare, Japan

向作者/读者索取更多资源

Background: In recent decades, Echovirus 30 (E30) and Japanese encephalitis virus (JEV) have been reported to be the common causative agents of acute meningitis among patients in South East Asia. An E30 outbreak in Vietnam in 2001-2002 gained our interest because the initial clinical diagnosis of infected patients was due to JEV infection. There are few clinical insights regarding E30 cases, and there are no reports comparing E30 and JEV acute meningitis/encephalitis cases based on clinical symptoms and case histories. We therefore aimed to identify reliable clinical methods to differentiate E30 and JEV acute meningitis/encephalitis. Methods: A retrospective, cross-sectional study was conducted to compare E30 and JEV acute meningitis/encephalitis cases. We collected and analyzed the clinical records of 43 E30 confirmed cases (E30 group) and 60 JEV confirmed cases (JEV group). Clinical data were compared between the E30 and the JEV groups. Differences of clinical parameters were analyzed by certain statistical tests. Results: Fever, headache, and vomiting were the most common symptoms in both the E30 and the JEV groups. Combined symptoms of headache and vomiting and the triad of symptoms of fever, headache, and vomiting were observed in more patients in the E30 group (E30 vs. JEV: 19% vs. 0%, p < 0.001; 74% vs. 27%, p < 0.001, respectively). On the other hand, strong neurological symptoms such as seizure (5% vs. 73%, p < 0.001) and altered consciousness (12% vs. 97%, p < 0.001) were manifested primarily in the JEV group. CSF leukocytosis was observed predominantly in the E30 group (80 vs. 18 cells/mu L, p = 0.003), whereas decreasing CSF sugar level was observed predominantly in the JEV group (58.7 vs. 46.9 mg/dL, p < 0.001). Conclusion: Fever, headache, vomiting, absence of neurological symptoms (seizure, altered consciousness), and presence of CSF leukocytosis are important parameters to consider in differentiating E30 from JEV cases during early infection. Then, proper measures can be adopted immediately to prevent the spread of the disease in the affected areas.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据